Health
Metformin treatment linked to slowed cognitive decline – WebWire
Metformin is the first-line treatment for most cases of type 2 diabetes and one of the most commonly prescribed medications worldwide, with millions of individuals using it to optimise their blood glucose levels. A new research study, conducted over six year…
Metformin is the first-line treatment for most cases of type 2 diabetes and one of the most commonly prescribed medications worldwide, with millions of individuals using it to optimise their blood glucose levels.
A new research study, conducted over six years in the Sydney Memory and Ageing Study in 1037 Australians (aged 70 to 90 years old at baseline), has revealed an additional effect: individuals with type 2 diabetes who used metformin experienced slower cognitive decline with lower dementi…
-
General22 hours agoVictorian government blocked fire service from pursuing US giant over PFAS contamination
-
Noosa News22 hours agoQueensland teachers strike for second time this year after rejecting 8 per cent wage rise
-
Noosa News13 hours agoWest Coast Eagles draftee Josh Lindsay wants to carry on Troy Selwood’s legacy
-
General14 hours agoLabor to squeeze public service, sparking warnings of job losses